BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 25679211)

  • 1. Stereospecificity of oligonucleotide interactions revisited: no evidence for heterochiral hybridization and ribozyme/DNAzyme activity.
    Hoehlig K; Bethge L; Klussmann S
    PLoS One; 2015; 10(2):e0115328. PubMed ID: 25679211
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A general strategy for effector-mediated control of RNA-cleaving ribozymes and DNA enzymes.
    Wang DY; Lai BH; Sen D
    J Mol Biol; 2002 Apr; 318(1):33-43. PubMed ID: 12054766
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spiegelzymes: sequence specific hydrolysis of L-RNA with mirror image hammerhead ribozymes and DNAzymes.
    Wyszko E; Szymański M; Zeichhardt H; Müller F; Barciszewski J; Erdmann VA
    PLoS One; 2013; 8(1):e54741. PubMed ID: 23382952
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spiegelzymes® mirror-image hammerhead ribozymes and mirror-image DNAzymes, an alternative to siRNAs and microRNAs to cleave mRNAs in vivo?
    Wyszko E; Mueller F; Gabryelska M; Bondzio A; Popenda M; Barciszewski J; Erdmann VA
    PLoS One; 2014; 9(1):e86673. PubMed ID: 24489764
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Photoswitch nucleic acid catalytic activity by regulating topological structure with a universal supraphotoswitch.
    Liang X; Zhou M; Kato K; Asanuma H
    ACS Synth Biol; 2013 Apr; 2(4):194-202. PubMed ID: 23656478
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A general approach for the use of oligonucleotide effectors to regulate the catalysis of RNA-cleaving ribozymes and DNAzymes.
    Wang DY; Lai BH; Feldman AR; Sen D
    Nucleic Acids Res; 2002 Apr; 30(8):1735-42. PubMed ID: 11937626
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of ribozyme activity with short oligonucleotides.
    Komatsu Y
    Biol Pharm Bull; 2004 Apr; 27(4):457-62. PubMed ID: 15056847
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mirror-Image Oligonucleotides: History and Emerging Applications.
    Young BE; Kundu N; Sczepanski JT
    Chemistry; 2019 Jun; 25(34):7981-7990. PubMed ID: 30913332
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene silencing nucleic acids designed by scanning arrays: anti-EGFR activity of siRNA, ribozyme and DNA enzymes targeting a single hybridization-accessible region using the same delivery system.
    Beale G; Hollins AJ; Benboubetra M; Sohail M; Fox SP; Benter I; Akhtar S
    J Drug Target; 2003 Aug; 11(7):449-56. PubMed ID: 15203934
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel mode of regulation of an RNA-cleaving DNAzyme by effectors that bind to both enzyme and substrate.
    Wang DY; Sen D
    J Mol Biol; 2001 Jul; 310(4):723-34. PubMed ID: 11453683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Catalytic molecular logic devices by DNAzyme displacement.
    Brown CW; Lakin MR; Stefanovic D; Graves SW
    Chembiochem; 2014 May; 15(7):950-4. PubMed ID: 24692254
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The model structure of the hammerhead ribozyme formed by RNAs of reciprocal chirality.
    Wyszko E; Popenda M; Gudanis D; Sarzyńska J; Belter A; Perrigue P; Skowronek P; Rolle K; Barciszewski J
    Biosci Rep; 2021 Jan; 41(1):. PubMed ID: 33351058
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent developments in oligonucleotide conjugation.
    Singh Y; Murat P; Defrancq E
    Chem Soc Rev; 2010 Jun; 39(6):2054-70. PubMed ID: 20393645
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design and kinetic analysis of hammerhead ribozyme and DNAzyme that specifically cleave TEL-AML1 chimeric mRNA.
    Choi WH; Choi BR; Kim JH; Yeo WS; Oh S; Kim DE
    Biochem Biophys Res Commun; 2008 Sep; 374(1):169-74. PubMed ID: 18627769
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expanding the catalytic repertoire of ribozymes and deoxyribozymes beyond RNA substrates.
    Franzen S
    Curr Opin Mol Ther; 2010 Apr; 12(2):223-32. PubMed ID: 20373266
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biological and functional aspects of catalytic RNAs.
    Castanotto D; Rossi JJ; Deshler JO
    Crit Rev Eukaryot Gene Expr; 1992; 2(4):331-57. PubMed ID: 1486242
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Site-specific cleavage of mutant ABL mRNA by DNAzyme is facilitated by peptide nucleic acid binding to RNA substrate.
    Kim JE; Yoon S; Mok H; Jung W; Kim DE
    FEBS Lett; 2012 Nov; 586(21):3865-9. PubMed ID: 23010596
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Self-assembly of a group I intron from inactive oligonucleotide fragments.
    Hayden EJ; Lehman N
    Chem Biol; 2006 Aug; 13(8):909-18. PubMed ID: 16931340
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Target-site selection for the 10-23 DNAzyme.
    Cairns MJ; Sun LQ
    Methods Mol Biol; 2004; 252():267-77. PubMed ID: 15017056
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A cross-chiral RNA polymerase ribozyme.
    Sczepanski JT; Joyce GF
    Nature; 2014 Nov; 515(7527):440-2. PubMed ID: 25363769
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.